1
|
Arevalo-Saenz A, Gonzalez-Alvaro I, Pulido-Rivas P, Vicente E, Garcia E, Castaneda S, Ocon E, Gomez-Leon N, Sola RG. [Medullar thoracic compression by tophaceous gout: presentation of a case and review of the literature]. Rev Neurol 2017; 65:368-372. [PMID: 28990647] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
INTRODUCTION Spine involvement in gout is an extremely uncommon complication. Dorsalgia and quadriplegia are some manifestations that may occur, although these symptoms are seen more frequently in other more prevalent pathologies, such as spinal tumors. CASE REPORT We present an unusual case of thoracic spinal cord compression at T10-T11 level caused by the extradural deposit of tophaceous material in a 52-year-old woman with uncontrolled chronic tophaceous gout. In addition to intensive medical treatment, the patient required surgery (hemilaminectomy and spinal decompression) and subsequent rehabilitation. Overall and neurological evolution were satisfactory.
Collapse
Affiliation(s)
| | | | - P Pulido-Rivas
- Hospital Universitario de la Princesa, 28006 Madrid, Espana
| | - E Vicente
- Hospital Universitario de la Princesa, 28006 Madrid, Espana
| | - E Garcia
- Hospital Universitario de la Princesa, 28006 Madrid, Espana
| | - S Castaneda
- Hospital Universitario de la Princesa, 28006 Madrid, Espana
| | - E Ocon
- Hospital Universitario de la Princesa, 28006 Madrid, Espana
| | - N Gomez-Leon
- Hospital Universitario de la Princesa, 28006 Madrid, Espana
| | - R G Sola
- Hospital Universitario de la Princesa, 28006 Madrid, Espana
| |
Collapse
|
2
|
Garcia Vadillo A, Garcia-Lorenzo E, Rodriguez-Serrano D, Llorente I, Merino L, Lopez-Bote J, Lopez-Fernandez M, Gonzalez-Alvaro I. AB0985 Clinical Characteristics and Mortality of Our Patients Admitted To ICU. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.2994] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
3
|
Leon L, Redondo M, Garcia-Vadillo A, Gonzalez-Alvaro I, Perez-Nieto M, Jover J, Abasolo L. SAT0647-HPR Patient Personality Influences The Prescription of Treatment for Rheumatoid Arthritis. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.4025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
4
|
Tornero J, Fernández-Nebro A, Blanco F, Gonzalez-Alvaro I, Sanmarti R, Maymo J, Ballina J, Fernández-Gutierrez B, Olive A, Corominas H, Erra A, Pluma A, Alonso A, Tortosa R, Lόpez Lasanta M, Marsal S. AB1128 Epidemiological Comparative Analysis in a Large Cohort of Rheumatoid Arthritis Patients: Results of the Spanish IMID Consortium. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.4056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
5
|
Lόpez-Lasanta M, Gonzalez-Alvaro I, Maymo J, Fernández-Gutierrez B, Ureña I, Blanco F, Cañete J, Alperi-Lόpez M, Olive A, Corominas H, Tornero J, Erra A, Almirall M, Palau N, Ortiz A, Avila G, Rodriguez-Rodriguez L, Alonso A, Tortosa R, Julia A, Marsal S. THU0015 IL2RA Locus is Associated with Joint Damage in a Specific Rheumatoid Arthritis Phenotype. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2981] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
6
|
Tomero E, Seoane I, Martinez C, Juarranz Y, Ortiz A, Garcia-Vicuña R, Gomariz R, Gonzalez-Alvaro I. THU0076 Vasoactive Intestinal Peptide in Serum: A Potential Disease Severity Marker in Patients with Early Spondyloarthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.4454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
7
|
Loza E, Lajas C, Andreu J, Balsa A, Gonzalez-Alvaro I, Illera O, Jover J, Mateo I, Orte J, Rivera J, Rodríguez Heredia J, Romero F, Martínez Lόpez J, Ortiz A, Toledano E, Villaverde V, Carmona L, Castañeda S. SAT0140 Recommendations for Investigating and Managing Comorbidity in Rheumatoid Arthritis: Table 1. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.3089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
8
|
Gonzalez-Alvaro I, Lamana A, Ortiz AM, Garcia-Vicuña R. THU0242 Effect of Genetic Variants in Proteins of the Folic Acid Metabolic Pathways in the Toxicity of Methotrexate. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.770] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
9
|
Lopez-Santalla M, Gonzalez-Alvaro I, Lamana A, Ortiz A, Castañeda S, Salvador J. AB0176 P38 MAPK phosphorylation as a rheumatoid arthritis biomarker. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.176] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
10
|
Acosta-Colman I, Palau N, Tornero J, Fernández-Nebro A, Blanco F, Gonzalez-Alvaro I, Cañete JD, Maymó J, Ballina J, Fernández-Gutierrez B, Olivé A, Corominas H, Erra A, Alonso A, López-Lasanta M, Tortosa R, Julià A, Marsal S. THU0006 PDE3A-SLCO1C1 Locus is Associated with the Response to Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
11
|
Leon L, Redondo M, Abasolo L, Garcia-Vadillo A, Gonzalez-Alvaro I, Arrieti L, Macarron P, Perez-Nieto MA, Jover JA. AB0829-HPR Influence of ra patient personality for more aggressive therapies. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.3151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
12
|
Ferreiro-Iglesias A, Calaza M, Perez-Pampin E, Lopez-Longo FJ, Marenco JL, Blanco FJ, Narvaez J, Navarro F, Cañete JD, Rodriguez-de-la-Serna A, Gonzalez-Alvaro I, Herrero-Beaumont G, Pablos JL, Balsa A, Fernandez-Gutierrez B, Caliz R, Gomez-Reino JJ, Gonzalez A. THU0001 Replication of Interactions Between Polymorphisms in Rheumatoid Arthritis Susceptibility. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
13
|
Castrejón I, Ortiz AM, García-Vicuña R, Lopez-Bote JP, Humbría A, Carmona L, Gonzalez-Alvaro I. Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis? Clin Exp Rheumatol 2008; 26:769-775. [PMID: 19032807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
UNLABELLED A formula for calculating disease activity score with 28 joint counts (DAS28) with C-reactive protein (CRP) instead of the erythrocyte sedimentation rate (ESR) has been proposed. OBJECTIVE Here we analyze the factors that contribute to the differences in the DAS28 when calculated using either the ESR (DAS28-ESR) or the CRP values (DAS28-CRP). METHODS We analyzed the data from 587 visits made by 220 patients with early arthritis. The age at the onset of the disease was 51+/-16 years old and 76.3% of the patients were women. The disease evolution at the first visit was 5 months and at each visit information related to several variables was collected, including that necessary to calculate the DAS28-ESR and DAS28-CRP. We defined a new variable DIFDAS=DAS28-ESR-DAS28-CRP to analyze which independent variables account for differences between the two indexes. RESULTS There was a correlation between the two indexes of 0.91 (p<0.0001), although the DAS28-ESR value obtained was higher than that of DAS28-CRP at approximately 90% of the visits. Significantly, the difference between both indexes was higher than 0.6 in 44% of the visits studied. A multivariate analysis showed that female gender and disease duration were associated with the higher values obtained for DAS28-ESR when compared to those of DAS28-CRP. CONCLUSION Our data show that DAS28-ESR and DAS28-CRP are not fully equivalent, because the former usually produces higher values. This finding is particularly relevant in females and patients with a long disease duration.
Collapse
Affiliation(s)
- I Castrejón
- Rheumatology Service, Hospital Universitario de la Princesa, Madrid, Spain
| | | | | | | | | | | | | |
Collapse
|
14
|
Dieguez-Gonzalez R, Akar S, Calaza M, Perez-Pampin E, Costas J, Torres M, Vicario JL, Velloso ML, Navarro F, Narvaez J, Joven B, Herrero-Beaumont G, Gonzalez-Alvaro I, Fernandez-Gutierrez B, de la Serna AR, Carreño L, Lopez-Longo J, Caliz R, Collado-Escobar MD, Blanco FJ, Fernandez-Lopez C, Balsa A, Pascual-Salcedo D, Gomez-Reino JJ, Gonzalez A. Genetic variation in the nuclear factor kappaB pathway in relation to susceptibility to rheumatoid arthritis. Ann Rheum Dis 2008; 68:579-83. [PMID: 18434448 DOI: 10.1136/ard.2007.087304] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVE To examine genetic association between rheumatoid arthritis (RA) and known polymorphisms in core genes of the nuclear factor (NF)kappaB pathway, the major intracellular pathway in RA pathogenesis. METHODS Discovery and replication sample sets of Spanish patients with RA and controls were studied. A total of 181 single nucleotide polymorphisms (SNPs) uniformly spaced along the genomic sequences of 17 core genes of the NFkappaB pathway (REL, RELA, RELB, NFKB1, NFKB2, NFKBIA, NFKBIB, NFKBIE, IKBKA, IKBKB, IKBKE, IKBKAP, KBRAS1, KBRAS2, MAP3K1, MAP3K14, TAX1BP1) were studied by mass spectrometry analysis complemented with 5'-nuclease fluorescence assays in the discovery set, 458 patients with RA and 657 controls. SNPs showing nominal significant differences were further investigated in the replication set of 1189 patients with RA and 1092 controls. RESULTS No clear reproducible association was found, although 12 SNPs in IKBKB, IKBKE and REL genes showed significant association in the discovery set. Interestingly, two of the SNPs in the IKBKE gene, weakly associated in the discovery phase, showed a trend to significant association in the replication phase. Pooling both sample sets together, the association with these two SNPs was significant. CONCLUSION We did not find any major effect among the explored members of the NFkappaB pathway in RA susceptibility. However, it is possible that variation in the IKBKE gene could have a small effect that requires replication in additional studies.
Collapse
Affiliation(s)
- R Dieguez-Gonzalez
- Laboratorio de Investigacion 2 and Rheumatology Unit, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Gonzalez-Alvaro I, Ortiz AM, Garcia-Vicuña R, Balsa A, Pascual-Salcedo D, Laffon A. Increased serum levels of interleukin-15 in rheumatoid arthritis with long- term disease. Clin Exp Rheumatol 2003; 21:639-42. [PMID: 14611115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/27/2023]
Abstract
OBJECTIVE To study the serum levels of IL-15 in patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), seronegative spondyloarthropathies (SSd) and healthy donors. METHODS The IL-15 serum levels were measured by ELISA in sera from 50 RA patients, 30 patients with SLE, 30 patients with SSd and 30 healthy donors. In RA patients, several clinical and demographic parameters were also obtained at the time of sample collection. IL-15 levels were compared in different RA subpopulations (positive or negative rheumatoid factor [RF], long term or recent onset disease, high or low disease activity). In addition, the possible association with other demographic and clinical parameters (gender, age, disease duration, etc) was also analysed. RESULTS RA patients had significantly higher serum levels of IL-15 (102.4 +/- 150 pg/ml; p = 0.0001) than SLE patients (9.8 +/- 15.3 pg/ml), SSd patients (7.9 +/- 14.6 pg/ml) and healthy donors' (5.2 +/- 11.6 pg/ml). RA patients with a disease evolution less than 2 years showed lower IL-15 levels (33.7 +/- 62.2 pg/ml) than those with long-term disease (152.4 +/- 64.6 pg/ml; p = 0.004). In addition, a significant correlation between IL15 in serum and the number of disease-modifying antirheumatic drugs (DMARDs) prescribed was detected in RA patients (r = 0.42; p = 0.002). No association between IL-15 levels and age, gender, RF or disease activity was observed in this group. CONCLUSION IL-15 is elevated in RA patients, specially in those with long term disease, compared to other rheumatic disorders. This finding supports that IL-15 is involved in the perpetuation of RA synovitis.
Collapse
Affiliation(s)
- I Gonzalez-Alvaro
- Rheumatology Department, Hospital Universitario de La Princesa, Madrid, Spain.
| | | | | | | | | | | |
Collapse
|